Maissa Mhibik

3PUBLICATIONS
23CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.

Anfal Alsadhan, Jonathan Chen, Erika M Gaglione

|Nov 28, 2022
Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia.

Matthew G Cyr, Maissa Mhibik, Junpeng Qi

|May 28, 2021
BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL.

Maissa Mhibik, Erika M Gaglione, David Eik

Pageof 1

Frequent Collaborators

2 joint publications

Clare Sun

2 joint publications

Christoph Rader

1 joint publications

David Eik

1 joint publications

Ellen K Kendall